Is plasma C3 and C4 levels useful in young cerebral ischemic stroke patients? Associations with prognosis at 3 months

Journal of Thrombosis and Thrombolysis

Volumn 39, Issue 2, 2015, Pages 209-214

  Zhang, Bin ^b   Yang, Ning ^b   Gao, Cong ^a,b  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Cerebral ischemic stroke; Complement C3 and C4; Young

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4;

ADULT; BLOOD; BRAIN ISCHEMIA; CHINA; FEMALE; HUMAN; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PREDICTIVE VALUE; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; STROKE; TIME FACTOR;

ADULT; BRAIN ISCHEMIA; CHINA; COMPLEMENT C3; COMPLEMENT C4; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS;

EID: 84939885619     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-014-1100-7     Document Type: Article

References (27)

1. Lindsberg PJ, Grau AJ (2003) Inflammation and infections as risk factors for ischemic stroke. Stroke 34:2518–2532
2. Danton GH, Dietrich WD (2003) Inflammatory mechanisms after ischemia and stroke. J Neuropathol Exp Neurol 62:127–136
3. Arenillas JF, Alvarez-Sabin J, Molina CA, Chacon P, Fernandez-Cadenas I, Ribo M et al (2008) Progression of symptomatic intracranial large artery atherosclerosis is associated with a proinflammatory state and impaired fibrinolysis. Stroke 39:1456–1463
4. Xi G, Hua Y, Keep RF, Younger JG, Hoff JT (2001) Systemic complement depletion diminishes perihematomal brain edema in rats. Stroke 32:162–167
5. Morgan BP, Gasque P, Singhrao S, Piddlesden SJ (1997) The role of complement in disorders of the nervous system. Immunopharmacology 38:43–50
6. Pedersen ED, Loberg EM, Vege E, Daha MR, Maehlen J et al (2009) In situ deposition of complement in human acute brain ischaemia. Scand J Immunol 69:555–562
7. Lindsberg PJ, Ohman J, Lehto T, Karjalainen-Lindsberg ML, Paetau A et al (1996) Complement activation in the central nervous system following bloodbrain barrier damage in man. Ann Neurol 40:587–596
8. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY (2004) Reference distributions for complement proteins C3 and C4: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal 18:1–8
9. Walport MJ (2001) Complement. First of two parts. N Engl J Med 355:1058–1066
10. Niculescu F, Rus H (2004) The role of complement activation in atherosclerosis. Immunol Res 30:73–80
11. Stokowska A, Olsson S, Holmegaard L, Jood K, Blomstrand C, Jern C et al (2011) Plasma C3 and C3a levels in cryptogenic and large-vessel disease stroke: associations with outcome. Cerebrovasc Dis 32(2):114–122
12. Mocco J, Mack WJ, Ducruet AF, Sosunov SA, Sughrue ME, Hassid BG et al (2006) Complement component C3 mediates inflammatory injury following focal cerebral ischemia. Circ Res 99:209–217
13. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL et al (1993) Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST: Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35–41
14. O’Malley T, Langhorne P, Elton RA, Stewart C (1995) Platelet size in stroke patients. Stroke 26:995–999
15. Pedersen ED, Waje-Andreassen U, Vedeler CA, Aamodt G, Mollnes TE (2004) Systemic complement activation following human acute ischaemic stroke. Clin Exp Immunol 137:117–122
16. Yang J, Ahn HN, Chang M, Narasimhan P, Chan PH, Song YS (2013) Complement component 3 inhibition by an antioxidant is neuroprotective after cerebral ischemia and reperfusion in mice. J Neurochem 124(4):523–535
17. Somani R, Grant PJ, Kain K, Catto AJ, Carter AM (2006) Complement C3 and C-reactive protein are elevated in South Asians independent of a family history of stroke. Stroke 37(8):2001–2006
18. Elvington A, Atkinson C, Zhu H, Yu J, Takahashi K, Stahl GL, Kindy MS, Tomlinson S (2012) The alternative complement pathway propagates inflammation and injury in murine ischemic stroke. J Immunol 189(9):4640–4647
19. Szeplaki G, Prohaszha Z, Duba J, Rugonfalvi-Kiss S, Karadi I, Kokai M et al (2004) Association of high serum concentration of the third component of complement (C3) with pre-existing severe coronary artery disease and new vascular events in women. Atherosclerosis 177:383–389
20. Ajjan R, Grant PJ, Futers TS, Brown JM, Cymbalista CM, Boothby M et al (2005) Complement C3 and C-reactive protein levels in patients with stable coronary artery disease. Thromb Haemost 94:1048–1053
21. Qiao F, Atkinson C, Kindy MS, Shunmugavel A, Morgan BP, Song H, Tomlinson S (2010) The alternative and terminal pathways of complement mediate post-traumatic spinal cord inflammation and injury. Am J Pathol 177:3061–3070
22. Leinhase I, Holers VM, Thurman JM, Harhausen D, Schmidt OI, Pietzcker M et al (2006) Reduced neuronal cell death after experimental brain injury in mice lacking a functional alternative pathway of complement activation. BMC Neurosci 7:55
23. Ducruet AF, Zacharia BE, Sosunov SA, Gigante PR, Yeh ML, Gorski JW et al (2012) Complement inhibition promotes endogenous neurogenesis and sustained anti-inflammatory neuroprotection following reperfused stroke. PLoS One 7(6):e38664. doi:10.1371/journal.pone.0038664
24. Muscari A, Bozzoli C, Massaelli G, Puddu GM, Palareti G, Legnani C et al (1995) Complement components and fibrinogen: correlations and association with previous myocardial infarction. Cardiology 86:232–237
25. Engström G, Hedblad B, Eriksson KF, Janzon L, Lindgärde F (2005) Complement C3 is a risk factor for the development of diabetes. A population-based cohort study. Diabetes 54:570–575
26. Gabrielsson BG, Johansson JM, Lönn M, Jernas M, Olbers T, Peltonen M et al (2003) High expression of complement components in omental adipose tissue in obese men. Obes Res 11:699–708
27. Engström G, Hedblad B, Janzon L, Lindgärde F (2007) Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study. Eur J Cardiovasc Prev Rehabil 14(3):392–397